Transfer pricing case
AstraZeneca, the FTSE 100 UK drug-maker, expects to settle a long-running tax dispute over transfer pricing with HM Revenue & Customs before the Special Commissioners.
The case, which has been deferred until April 2010, is likely to set a precedent for other companies which transfer goods and services between countries.
It seems a long time to wait but some further clarity would be welcomed.
Date: 30th January, 2009
Articles from this Author
20th July, 2017
Uncertain times for winding up transactions
3rd July, 2017
9th June, 2017
27th April, 2017
Government places Making Tax Digital legislation on hold
Contact Business Service Partners
Choose from the drop down menu below to select a Partner to contact.
For the latest Mercer & Hole news, visit our LinkedIn page mercer-&-hole